Circulation 1995-11-01

Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts.

T Hiramatsu, J Forbess, T Miura, S J Roth, M A Cioffi, J E Mayer

Index: Circulation 92(9 Suppl) , II400-4, (1995)

Full Text: HTML

Abstract

Prior studies suggest an important role for coronary endothelium in ischemia/reperfusion (I/R) injury. Decreased endothelial release of the vasodilator nitric oxide occurs after I/R, but the role of the endothelium-derived vasoconstrictor endothelin-1 (ET-1) in I/R is unknown.We measured plasma ET-1 concentrations by radioimmunoassay in isolated blood-perfused neonatal lamb hearts before and after 2 hours of 10 degrees C cardioplegic ischemia and examined the effects of ET-1 and the endothelin-A (ET-A) receptor antagonist BE-18257B on the postischemic recovery of isolated hearts. ET-1 levels in coronary sinus blood before ischemia and at 0 and 30 minutes of reperfusion in 8 control hearts were constant (2.2 +/- 1.2 fmol/L, 2.2 +/- 1.3 fmol/L, and 2.5 +/- 1.0 fmol/L, respectively). In group 2 (n = 6), 10 mumol/L of BE-18257B was given just before reperfusion. In group 3 (n = 8), 10 pmol/L ET-1 was given just before the start of reperfusion. At 30 minutes of reperfusion, the ET-A antagonist hearts had significantly greater recovery of LV systolic (positive dP/dt and dP/dt at V10) and diastolic function (negative dP/dt), coronary blood flow (CBF), and MVo2 compared with controls (P < .05). The ET-1 hearts showed significantly reduced recovery of LV systolic (positive maximum and volume-normalized dP/dt) and diastolic (negative maximum dP/dt) function, CBF, and myocardial oxygen consumption compared with controls (P < .05).These results, combined with prior studies, suggest that I/R causes reduced production of endogenous vasodilators (eg, nitric oxide), leaving unopposed the vasoconstriction that is caused by the continued presence of ET-1. This imbalance may contribute to I/R injury. ET-A receptor antagonists may be useful therapeutic agents in reducing the injury that results from I/R.


Related Compounds

  • BE-18257B

Related Articles:

An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis.

1991-07-15

[Biochem. Biophys. Res. Commun. 178 , 132, (1991)]

[Agonists and antagonists to endothelin receptors].

1993-08-01

[Tanpakushitsu Kakusan Koso. 38(11) , 1827-40, (1993)]

Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder.

1994-02-01

[Br. J. Pharmacol. 111(2) , 473-82, (1994)]

A conformational study by 1H NMR of a cyclic pentapeptide antagonist of endothelin.

1993-09-03

[J. Med. Chem. 36(18) , 2658-65, (1993)]

Endothelin-binding inhibitors, BE-18257A and BE-18257B. I. Taxonomy, fermentation, isolation and characterization.

1991-12-01

[J. Antibiot. 44(12) , 1342-7, (1991)]

More Articles...